Stocks and Investing
Stocks and Investing
Mon, April 22, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Vikram Purohit Maintained (ASND) at Hold and Held Target at $116 on, Apr 22nd, 2024
Vikram Purohit of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Hold and Held Target at $116 on, Apr 22nd, 2024.
Vikram has made no other calls on ASND in the last 4 months.
There are 5 other peers that have a rating on ASND. Out of the 5 peers that are also analyzing ASND, 0 agree with Vikram's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Vikram
- Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $173 on, Thursday, April 18th, 2024
- Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $167 on, Tuesday, April 2nd, 2024
- Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $260 on, Friday, March 15th, 2024
- Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $225 on, Thursday, February 8th, 2024
- David Lebowitz of "Citigroup" Maintained at Strong Buy with Increased Target to $182 on, Thursday, February 8th, 2024
Contributing Sources